Asset Management One
AZN icon

Asset Management One’s AstraZeneca AZN Stock Holding History

Asset Management One’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59
Closed -$10.8K – 915
2025
Q4 		$10.8K Buy
59
+3
+5% +$526 ﹤0.01% 936
2025
Q3 		$8.59K Sell
56
-5
-8% -$757 ﹤0.01% 945
2025
Q2 		$8.53K Buy
61
+1
+2% +$140 ﹤0.01% 943
2025
Q1 		$8.75K Buy
60
+6
+11% +$868 ﹤0.01% 957
2024
Q4 		$7.09K Sell
54
-24
-31% -$3.36K ﹤0.01% 950
2024
Q3 		$12.1K Buy
78
+2
+3% +$323 ﹤0.01% 955
2024
Q2 		$11.8K Buy
76
+4
+6% +$602 ﹤0.01% 956
2024
Q1 		$9.69K Buy
72
+8
+13% +$1.06K ﹤0.01% 970
2023
Q4 		$8.61K Buy
+64
New +$8.32K ﹤0.01% 973
2015
Q1 		– Sell
-123,744
Closed -$8.76M – 1342
2014
Q4 		$8.76M Buy
123,744
+9,364
+8% +$671K 0.11% 240
2014
Q3 		$8.23M Buy
+114,380
New +$8.37M 0.11% 221

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Asset Management One's AZN Position: Q1 2026 in Review

Asset Management One sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 59 shares — an estimated $10.8K sold.

Asset Management One first reported a position in AZN in Q3 2014 and held it in 11 quarters. The position peaked at $8.76M in Q4 2014. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Asset Management One reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Asset Management One sold 59 AstraZeneca shares in Q1 2026, an estimated $10.8K.
  • Asset Management One first reported a position in AstraZeneca in Q3 2014 and held it in 11 quarters.
  • Asset Management One's AstraZeneca position peaked at $8.76M in Q4 2014.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.